GILEAD SCIENCES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Gilead Sciences, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2024.
  • Gilead Sciences, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.36B, a 3.2% increase year-over-year.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$5.13B, a 20.8% increase from 2022.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$6.47B, a 27.1% increase from 2021.
  • Gilead Sciences, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$8.88B, a 1253% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$1.36B +$45M +3.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q1 2023 -$1.41B +$388M +21.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 -$1.79B +$683M +27.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-03
Q1 2021 -$2.48B +$134M +5.13% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q1 2020 -$2.61B -$245M -10.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q1 2019 -$2.37B +$4.23B +64.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q1 2018 -$6.6B -$5.35B -430% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q1 2017 -$1.24B +$7.37B +85.6% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q1 2016 -$8.61B -$5.89B -216% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q1 2015 -$2.72B -$5.61B -194% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q1 2014 $2.88B +$3.08B Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q1 2013 -$199M -$2.05B -111% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $1.86B +$1.37B +283% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 $485M +$469M +2926% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04
Q1 2010 $16M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.